Bao W, Ballard VL, Needle S, Hoang B, Lenhard SC, Tunstead JR, Jucker BM, Willette RN, Pipes GT. Cardioprotection by systemic dosing of thymosin beta four following ischemic myocardial injury. Front Pharmacol. November 2013;4:149.
Full Text – Open Access
Publication Date
November 2013
How Analyze was Used
“Cardiac image analysis was performed using Analyze 8.1 AVW software (AnalyzeDirect, Lenexa KS).”
Keywords
Angiogenesis
Ischemia/reperfusion
Myocardial Ischemia
Thymosin Beta Four
Author Affiliation(s)
Metabolic Pathways and Cardiovascular Unit, GlaxoSmithKline Pharmaceuticals King of Prussia, PA, US. (WB, VLB, SN, SCL, BMJ, RNW, GTP)
Platform Technology and Science, GlaxoSmithKline Pharmaceuticals King of Prussia, PA, US. (BH, JRT)
ID# 234
Tags: Angiogenesis, Ischemia/reperfusion, Myocardial Ischemia, Thymosin Beta Four